Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors.

[1]  Qifu Li,et al.  Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population , 2022, Annals of Internal Medicine.

[2]  T. Dandekar,et al.  Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability , 2022, Journal of mass spectrometry and advances in the clinical lab.

[3]  D. J. Ramsey,et al.  Missed Opportunities to Promptly Diagnose and Treat Adrenal Tumors. , 2022, The Journal of surgical research.

[4]  A. Buck,et al.  Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses , 2021, European journal of endocrinology.

[5]  E. Caoili,et al.  18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Non-Cancer Patients. , 2021, The Journal of clinical endocrinology and metabolism.

[6]  H. Escobar-Morreale,et al.  Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review , 2020, Endocrine.

[7]  W. Young,et al.  Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. , 2020, The lancet. Diabetes & endocrinology.

[8]  E. Baudin,et al.  Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Michael Biehl,et al.  Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study , 2020, The lancet. Diabetes & endocrinology.

[10]  A. Scarsbrook,et al.  Adrenal Incidentaloma , 2020, Endocrine reviews.

[11]  B. Vogt,et al.  Urinary steroid profiles: comparison of spot and 24-hour collections , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  L. Gerber,et al.  Addressing the problem of inaccuracy of measured 24‐hour urine collections due to incomplete collection , 2019, Journal of clinical hypertension.

[13]  U. Maestroni,et al.  Magnetic resonance imaging of adrenal gland: state of the art. , 2019, Gland surgery.

[14]  Eric Baudin,et al.  European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. , 2018, European journal of endocrinology.

[15]  A. Tabarin,et al.  Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population. , 2018, European journal of endocrinology.

[16]  E. A. Bessonova,et al.  Urinary steroid profiling by gas chromatography mass spectrometry: Early features of malignancy in patients with adrenal incidentalomas , 2018, Steroids.

[17]  W. Young,et al.  High-Resolution, Accurate-Mass (HRAM) Mass Spectrometry Urine Steroid Profiling in the Diagnosis of Adrenal Disorders. , 2017, Clinical chemistry.

[18]  J. Deeks,et al.  MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis , 2016, European journal of endocrinology.

[19]  A. Tabarin,et al.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.

[20]  E. Bessonova,et al.  Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma , 2016, Hormones and Cancer.

[21]  B. K. Park,et al.  Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses. , 2016, The British journal of radiology.

[22]  I. Kema,et al.  Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors , 2015, Hormones and Cancer.

[23]  Achim Zeileis,et al.  Partykit: a modular toolkit for recursive partytioning in R , 2015, J. Mach. Learn. Res..

[24]  J. Dieleman,et al.  Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. , 2013, European journal of cancer.

[25]  Michael Biehl,et al.  Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors , 2011, The Journal of clinical endocrinology and metabolism.

[26]  Beppie van den Bogaerde,et al.  Clinical practice , 2011, European Journal of Pediatrics.

[27]  E. Papini,et al.  AME position statement on adrenal incidentaloma. , 2011, European journal of endocrinology.

[28]  N. Taylor,et al.  Use of urinary steroid profiling for diagnosing and monitoring adrenocortical tumours. , 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

[29]  Herb Chen,et al.  Revisiting adrenal mass size as an indication for adrenalectomy. , 2009, The Journal of surgical research.

[30]  K. Hornik,et al.  Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .

[31]  B. Astor,et al.  Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. , 2004, The Journal of rheumatology.

[32]  E. Balk,et al.  The clinically inapparent adrenal mass: update in diagnosis and management. , 2004, Endocrine reviews.

[33]  A. Dackiw,et al.  Limitations of size as a criterion in the evaluation of adrenal tumors. , 2000, Surgery.

[34]  G. Arnaldi,et al.  A Survey on Adrenal Incidentaloma in Italy , 2000 .

[35]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[36]  L Hagenäs,et al.  Steroid profile in urine: a useful tool in the diagnosis and follow up of adrenocortical carcinoma. , 1990, Acta endocrinologica.

[37]  K Kinoshita,et al.  Measurement of urinary steroid profile in patients with adrenal tumor as a screening method for carcinoma. , 1985, Endocrinologia japonica.